ArticleCureus2025
Pseudomyxoma Peritonei With Suspected Gastroesophageal Junction Mass: A Rare and Atypical Presentation.
Article in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pseudomyxoma peritonei (PMP) is a rare clinical entity characterized by the accumulation of mucinous ascites and peritoneal implants, most commonly originating from appendiceal or ovarian neoplasms. Its diagnosis is often delayed due to vague and nonspecific symptoms. We report the case of a 75-year-old female who presented with diffuse abdominal pain, melena, and significant weight loss. Clinical evaluation revealed ascites, and imaging suggested a possible gastroesophageal (GE) malignancy. Ascitic fluid analysis was inconclusive. Due to the markedly distended abdomen and unclear primary pathology, a diagnostic laparotomy was performed. Intraoperatively, mucinous ascites and widespread peritoneal deposits were noted without an identifiable primary tumor. Histopathological analysis confirmed PMP. MRI and contrast-enhanced CT (CECT) are valuable tools in the diagnosis of PMP, with characteristic features such as visceral scalloping aiding differentiation from other ascitic conditions. Cytoreductive surgery (CRS) with hyperthermic intraperitoneal chemotherapy (HIPEC) remains the gold standard for treatment. However, in this case, the patient's condition rapidly deteriorated, and she succumbed to multiorgan dysfunction before definitive therapy could be initiated. This report underscores the importance of early suspicion, timely surgical intervention, and referral to specialized centers in managing atypical presentations of PMP.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.